Ignite Creation Date:
2024-05-06 @ 5:46 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05425719
Status:
COMPLETED
Last Update Posted:
2024-04-18
First Post:
2022-04-21
Brief Title:
Pharmacokinetics and Safety of MB-102 Relmapirazin and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects
Sponsor:
MediBeacon
Organization:
MediBeacon
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-21
First Submit QC Date:
June 15 2022
Study First Post Date:
2022-06-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-04-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-22
Last Update Post Date:
2024-04-18
Last Update Post Date Type:
ACTUAL